On the morning of September 4, the 17th China Bioindustry Conference grandly opened at the China Optics Valley Science and Technology Convention and Exhibition Center in Wuhan. Qiu Xuewen, general manager of Wuhan Half the Sky, attended the opening ceremony of the conference. As a domestic medical device benchmark enterprise and a special supporter of the exhibition, Wuhan Half the Sky was invited to participate in the 17th China Bioindustry Conference and presented a series of gynecological and surgical minimally invasive surgical solutions. The scene attracted much attention and received an enthusiastic response.

This conference is co-sponsored by 17 national academic associations, including the Chinese Society for Bioengineering, and China Science News. With the theme of “Biotechnology Empowers the Future, Biomanufacturing Reshapes the World”, it brings together national leaders, academicians of the two academies, representatives of Fortune 500 companies, and industry elites to showcase the latest achievements and development trends in the field of biotechnology and biomanufacturing in my country. It is the largest, highest-level, and most influential comprehensive brand event in the field of biotechnology and bio-industry in my country.
During the exhibition, Wuhan Half the Sky’s products were simultaneously unveiled at the Half the Sky booth and the Optics Valley Biocity booth, attracting many representatives from medical companies and scientific researchers to come for consultation. Half the Sky staff won unanimous praise from the audience through professional and detailed product explanations and vivid and intuitive operation demonstrations. After trial use, many medical practitioners spoke highly of the excellent performance and high clinical adaptability of Half the Sky products.




With more than 20 years of technology accumulation in the medical device industry, the product lines exhibited by Wuhan Half the Sky cover the needs of multiple clinical disciplines, fully reflecting its full-chain R&D and industrialization capabilities of “starting from clinical needs and extending to market innovation.”
In the field of gynecology, the company’s independently developed Virgina treatment system has become a star product in the field of pelvic floor repair with its significant advantages of “matrix radio frequency, deep energy concentration, full pelvic effect, and immediate results”; in the field of surgery, radiofrequency ultrasonic scalpel surgical equipment, anastomotic hemostasis instruments, and minimally invasive anorectal, nail and breast surgical solutions are recognized and favored by many surgeons due to their precise, efficient and reliable operation. In addition, Wuhan Half the Sky also exhibited electrosurgical equipment suitable for precise operations of medical beauty, comprehensively promoting my country’s high-end medical equipment from technological breakthrough to ecological reconstruction.

More than ten professional sub-forums were also held during the conference. Among them, the “High-end Medical Equipment and Technology Innovation Forum” specially supported by Wuhan Half the Sky conducted in-depth discussions on key issues such as innovative research and development, clinical application and industrialization results of high-end medical equipment.
Representatives from Wuhan Half the Sky delivered a sharing at the forum titled “From “Stuck Neck” to “Strong Chain”: Chinese Innovation Paradigm to Break Technology Monopoly”. Starting from the company’s own innovation process, he systematically sorted out the paths and thoughts on achieving key technological breakthroughs in the fields of high-end equipment such as ultrasonic scalpels and radiofrequency treatment systems. At the same time, from multiple dimensions such as technological breakthroughs, product iterations, and value strategies, he explained the company’s strategic layout and practical experience in promoting localization and substitution of high-end medical equipment. The response was enthusiastic and applause continued.
As a medical company rooted in Wuhan and developing steadily, Wuhan Half the Sky has always insisted on using innovation as the engine of corporate development. Relying on its deep accumulation in the fields of ultrasound and radio frequency technology, it continues to increase investment in research and development, and continues to deepen industry-university-research collaboration with universities, scientific research institutes and medical institutions.
Qiu Xuewen, general manager of Wuhan Half the Sky, said that in the future, the company will further build and improve the high-end minimally invasive medical device product system, with a full-chain strategic layout, and is committed to promoting the transformation, upgrading and technological innovation of China’s medical device industry, and contributing more to realizing independent controllability of high-end medical equipment and improving the level of national health services!